How Much Does Provigil (Modafinil) Cost in Nebraska in 2026?

Nebraska Retail Pharmacy Prices for Modafinil

The average cash price for a 30-day supply of generic modafinil 200 mg at Nebraska retail pharmacies sits near $80 in 2026. Brand-name Provigil, manufactured by Cephalon (now a Teva subsidiary), carries a list price of roughly $850 per month. That gap matters. The branded product and every generic contain the same active compound, and the FDA requires bioequivalence testing before approving any generic formulation.

Prices vary across the state. Pharmacies in Omaha and Lincoln tend to cluster near the $80 average, while smaller towns may price slightly higher due to lower dispensing volume. Warehouse clubs like Costco and Sam's Club (both present in Omaha and Lincoln) often undercut chain pharmacies by 15% to 30% for cash-pay customers, even without a membership for pharmacy purchases. The original US Modafinil in Narcolepsy Study Group trial (N=283) established modafinil's efficacy for excessive daytime sleepiness, with significantly improved sleep latency on the Maintenance of Wakefulness Test compared to placebo [1]. That trial, published in Annals of Neurology in 1998, formed the clinical backbone for FDA approval of Provigil.

Pharmacy benefit managers negotiate different rates for different networks. A patient paying entirely out of pocket should request the "cash price" explicitly, because the insurance-adjudicated price without meeting a deductible can sometimes exceed the straight cash cost.

Nebraska Medicaid Does Not Cover Provigil

Nebraska Medicaid, administered through Heritage Health managed care plans (Nebraska Total Care, Healthy Blue, UnitedHealthcare Community Plan), does not include Provigil or generic modafinil on its preferred drug list as of 2026. This applies to both brand and generic formulations.

The omission is not unique to Nebraska. Many state Medicaid programs exclude modafinil or restrict it severely, partly because of its Schedule IV classification under the Controlled Substances Act and partly because of off-label demand that drives utilization management concerns. Medicaid recipients in Nebraska who have a confirmed narcolepsy diagnosis could pursue a medical exception request, but approval rates for modafinil exceptions are low in states that exclude it from formulary.

An alternative path: some Nebraska Medicaid enrollees with narcolepsy may qualify for sodium oxybate (Xyrem) or pitolisant (Wakix), which are on certain Heritage Health formularies for narcolepsy specifically. Neither drug is a direct substitute for modafinil pharmacologically. Sodium oxybate acts on GABA-B receptors and requires nighttime dosing, while pitolisant is a histamine H3 receptor inverse agonist. A 2013 Cochrane review of drugs for narcolepsy found modafinil effective for daytime sleepiness with a favorable side-effect profile relative to older amphetamine-based stimulants [2].

Patients denied Medicaid coverage should ask their prescriber about filing a formal appeal with the managed care organization, citing clinical necessity and the absence of therapeutic alternatives that have worked for that patient.

Commercial Insurance Coverage in Nebraska

Most commercial insurers operating in Nebraska, including Blue Cross Blue Shield of Nebraska, Medica, Aetna, and UnitedHealthcare, cover generic modafinil for FDA-approved indications. Prior authorization is the standard gatekeeper. Plans typically require documentation of a sleep study confirming narcolepsy or obstructive sleep apnea, or verification of a shift work schedule for shift work disorder.

Copay tiers vary. On a typical three-tier formulary, generic modafinil falls on Tier 2 (preferred generic) or Tier 3 (non-preferred generic), producing copays of $15 to $50 per month depending on the plan. Brand Provigil, if covered at all, lands on Tier 4 (specialty) or is excluded entirely with a mandatory generic substitution policy.

Off-label use for cognitive enhancement or fatigue not associated with an approved diagnosis almost always results in a denial. The American Academy of Sleep Medicine clinical practice guidelines recommend modafinil as a first-line wake-promoting agent for narcolepsy but do not endorse it for general fatigue or cognitive enhancement [3]. Insurers follow these guidelines closely when adjudicating prior authorizations.

Nebraska residents on employer-sponsored plans should check whether their pharmacy benefit is carved out to a separate PBM (Express Scripts, CVS Caremark, OptumRx). The PBM's formulary, not the medical insurer's, determines drug coverage and tier placement. Calling the number on the back of the pharmacy benefit card is the fastest way to confirm.

Compounded Modafinil in Nebraska: Legal and Available

Compounded modafinil is legal in Nebraska when dispensed by a pharmacy operating under a valid 503A license from the FDA. Section 503A of the Federal Food, Drug, and Cosmetic Act permits state-licensed pharmacies to compound medications for individual patients based on a valid prescription. Nebraska's Board of Pharmacy regulates these facilities under Nebraska Revised Statutes Chapter 71.

A 503A compounding pharmacy can prepare modafinil in custom doses (for example, 50 mg or 150 mg tablets for patients who need dose adjustments not available in commercial formulations) or in alternative delivery forms such as sublingual troches or suspensions. Pricing from compounding pharmacies varies widely. Some telehealth platforms that partner with 503A pharmacies advertise modafinil at no additional cost beyond a consultation fee, though patients should verify what that consultation fee includes.

Key distinctions patients should understand: compounded modafinil is not FDA-approved in the compounded form. The active ingredient is the same, but the final product has not undergone the same manufacturing controls or bioequivalence testing as a commercially manufactured generic. The FDA's guidance on 503A compounding makes clear that compounded drugs should be used when a commercial product does not meet a patient's medical need, not simply as a cheaper alternative [4].

Nebraska does not impose additional state-level restrictions on modafinil compounding beyond federal 503A requirements and state pharmacy board licensure. Patients ordering from out-of-state 503A pharmacies should confirm the pharmacy is licensed to ship into Nebraska.

Telehealth Prescribing of Modafinil in Nebraska

Nebraska permits telehealth prescribing of Schedule IV controlled substances, including modafinil. The state adopted permanent telehealth prescribing provisions following pandemic-era expansions. The Nebraska DHHS Credentialing Division requires that the prescribing provider hold an active Nebraska medical license or operate under an interstate compact that covers Nebraska.

A typical telehealth modafinil consultation costs $100 to $200 for the initial visit, with follow-ups at $50 to $100. Several national telehealth platforms serve Nebraska patients specifically for wakefulness medications. The prescriber must establish a valid provider-patient relationship, which in Nebraska can be done via synchronous audio-video telemedicine without requiring an initial in-person visit for Schedule IV prescriptions.

After the prescription is written, it can be sent electronically to any Nebraska retail pharmacy or to an out-of-state mail-order pharmacy licensed to ship into Nebraska. Electronic prescribing of controlled substances (EPCS) is now standard; the DEA's EPCS rule has been widely adopted by Nebraska pharmacies and prescribers.

One practical consideration: some telehealth platforms bundle the prescription with pharmacy fulfillment through a partner 503A pharmacy. This can simplify the process but may limit the patient's ability to use insurance, since compounded medications are rarely covered by commercial plans. Patients who want insurance coverage should request that the prescription be sent to their preferred retail pharmacy instead.

Discount Programs and Savings Cards

Manufacturer savings cards for brand Provigil are limited now that multiple generics are available. Cephalon (Teva) periodically offers copay assistance for commercially insured patients, but these programs typically exclude cash-pay, Medicare, Medicaid, and government-insured patients.

More practical savings options in Nebraska include:

Pharmacy discount cards. GoodRx, RxSaver, and SingleCare frequently show generic modafinil 200 mg (30 tablets) at $25 to $45 at Nebraska pharmacies. These prices can beat insurance copays, especially for patients on high-deductible health plans who have not met their deductible. The discount is applied at the pharmacy counter using a BIN/PCN/Group number; no enrollment or fee is required.

Mark Cuban Cost Plus Drug Company. Cost Plus Drugs lists generic modafinil with transparent cost-plus pricing (manufacturer cost plus 15% margin plus $5 pharmacy fee plus shipping). Prices typically fall between $10 and $30 for a 30-day supply. The pharmacy ships nationwide, including to Nebraska.

Manufacturer patient assistance programs. Patients with household incomes below 200% of the federal poverty level may qualify for free generic modafinil through programs like NeedyMeds or RxAssist, which aggregate manufacturer and independent charity assistance.

A 2020 analysis published in JAMA Internal Medicine found that pharmacy discount cards offered lower prices than insurance copays for 44% of the low-cost generics studied [5]. For a medication like modafinil, checking both the insured price and the discount card price before filling each prescription is a simple habit that can save $20 to $50 monthly.

Modafinil Pharmacology and Dosing Basics

Modafinil's mechanism is not completely characterized, which is unusual for a drug approved since 1998. The prevailing hypothesis involves inhibition of the dopamine transporter (DAT), increasing extracellular dopamine in the prefrontal cortex and hypothalamus. A 2009 study using PET imaging in human subjects confirmed that modafinil occupies DAT binding sites, supporting a dopaminergic mechanism [6]. Unlike amphetamines, modafinil does not produce significant norepinephrine or serotonin release at therapeutic doses, which likely explains its lower abuse potential.

The standard dose is 200 mg taken once daily in the morning. For shift work disorder, the dose is taken 1 hour before the start of the work shift. Doses above 200 mg have not shown additional benefit in controlled trials. The Provigil prescribing information notes that 400 mg daily was "no more effective" than 200 mg for narcolepsy or obstructive sleep apnea [7].

Half-life is approximately 12 to 15 hours. Patients should take the dose early enough to avoid interference with nighttime sleep. Common adverse effects include headache (34% in clinical trials vs. 23% placebo), nausea (11% vs. 3%), and anxiety (5% vs. 1%). Serious but rare adverse effects include Stevens-Johnson syndrome, with an estimated incidence of approximately 1 per 100,000 patient-years based on postmarketing surveillance data reported to the FDA [8].

Drug interactions relevant to Nebraska patients: modafinil induces CYP3A4, which can reduce the effectiveness of hormonal contraceptives. Women using oral contraceptives should use an additional barrier method during modafinil treatment and for one month after discontinuation, per the FDA label.

How Nebraska Compares to Neighboring States

Nebraska's modafinil pricing and access profile is broadly similar to Iowa, Kansas, South Dakota, and Colorado. Generic cash prices across all five states cluster in the $60 to $100 range. Nebraska Medicaid's non-coverage of modafinil mirrors Iowa and Kansas. Colorado Medicaid does cover generic modafinil with prior authorization, making it an outlier in the region.

For Nebraska residents near the Iowa or Colorado borders, there is no practical advantage to filling a prescription across state lines. Controlled substance prescriptions written by a Nebraska-licensed prescriber are valid at pharmacies in other states, but cash prices are comparable, and insurance networks are state-specific.

The CDC's National Health and Nutrition Examination Survey (NHANES) data from 2017 to 2020 estimated that 4.7% of U.S. adults report excessive daytime sleepiness, with prevalence slightly higher in rural populations [9]. Nebraska's substantial rural population may face additional access barriers, including fewer sleep medicine specialists and longer travel times for in-person sleep studies. Telehealth fills part of this gap, but home sleep apnea testing (which can justify a modafinil prescription for residual sleepiness in OSA) requires equipment that must be shipped or picked up.

Practical Steps to Minimize Your Modafinil Cost in Nebraska

Start with your insurance formulary. If generic modafinil is covered and you have met your deductible, your copay may be the lowest price available. If you have not met your deductible or your plan excludes modafinil, check GoodRx or SingleCare at your preferred pharmacy before filling.

For patients without insurance, Cost Plus Drugs or a discount card at a warehouse pharmacy will likely produce the lowest per-tablet price. A 90-day fill, where allowed by the prescriber, often reduces the per-unit cost further and saves on dispensing fees.

Patients considering compounded modafinil through a telehealth platform should compare the total cost (consultation fee plus medication cost plus shipping) against the retail generic price with a discount card. If the total exceeds $80, the retail pharmacy route is cheaper.

Request the 200 mg tablet and split it in half if your prescribed dose is 100 mg. Modafinil 200 mg tablets are scored and approved for splitting. The 100 mg and 200 mg tablets are often priced identically, so splitting effectively halves your medication cost. A systematic review in the American Journal of Health-System Pharmacy confirmed that tablet splitting of scored oral solid dosage forms produces acceptable dose uniformity for most medications [10].

Keep your prescription current. Nebraska pharmacies cannot dispense a Schedule IV controlled substance on an expired prescription, and refills are limited to five within six months of the original date written.